1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.05%
Positive EBIT growth while ACB.TO is negative. John Neff might see a substantial edge in operational management.
22.05%
Positive operating income growth while ACB.TO is negative. John Neff might view this as a competitive edge in operations.
22.04%
Positive net income growth while ACB.TO is negative. John Neff might see a big relative performance advantage.
21.74%
EPS growth under 50% of ACB.TO's 88.68%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
21.74%
Diluted EPS growth under 50% of ACB.TO's 88.68%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
93.50%
Positive OCF growth while ACB.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
93.50%
Positive FCF growth while ACB.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-102.50%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-102.50%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-102.50%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
73.12%
Positive 10Y CAGR while ACB.TO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
73.12%
Positive 5Y CAGR while ACB.TO is negative. John Neff might view this as a strong mid-term relative advantage.
73.12%
Positive short-term CAGR while ACB.TO is negative. John Neff would see a clear advantage in near-term profit trajectory.
-79.29%
Negative equity/share CAGR over 10 years while ACB.TO stands at 15.27%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-79.29%
Negative 5Y equity/share growth while ACB.TO is at 1.41%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-79.29%
Negative 3Y equity/share growth while ACB.TO is at 33.81%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-60.53%
Firm’s AR is declining while ACB.TO shows 239.62%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-8.43%
Negative asset growth while ACB.TO invests at 167.05%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-9.38%
We have a declining book value while ACB.TO shows 195.80%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
352.04%
SG&A growth well above ACB.TO's 646.27%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.